Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group

M.S. Aapro; F.H. van Wijk; G. Bolis; B. Chevallier; M.E.L. van der Burg; A. Poveda; C.F. de Oliveira; S. Tumolo; V. Scotto di Palumbo; M. Piccart; M. Franchi; F. Zanaboni; A.J. Lacave; R. Fontanelli; G. Favalli; P. Zola; J.P. Guastalla; R. Rosso; C. Marth; M. Nooij; M. Presti; C. Scarabelli; T.A.W. Splinter; E. Ploch; L.V.A. Beex; W. ten Bokkel Huinink; M. Forni; M. Melpignano; P. Blake; P. Kerbrat; C. Mendiola; A. Cervantes; A. Goupil; P.G. Harper; C. Madronal; M. Namer; G. Scarfone; J.E.G.M. Stoot; I. Teodorovic; C. Coens; I. Vergote; J.B. Vermorken

doi:10.1093/annonc/mdg112

Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group

Annals of Oncology ◽

10.1093/annonc/mdg112 ◽

2003 ◽

Vol 14 (3) ◽

pp. 441-448 ◽

Cited By ~ 158

Author(s):

M.S. Aapro ◽

F.H. van Wijk ◽

G. Bolis ◽

B. Chevallier ◽

M.E.L. van der Burg ◽

...

Keyword(s):

Endometrial Carcinoma ◽

Gynaecological Cancer ◽

Randomised Study ◽

Cancer Group

Download Full-text

Faculty Opinions recommendation of Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1108607.564761 ◽

2008 ◽

Author(s):

Robert Maki

Keyword(s):

Study Protocol ◽

Gynaecological Cancer ◽

Phase Iii ◽

Pelvic Radiotherapy ◽

Uterine Sarcomas ◽

Randomised Study ◽

European Organisation ◽

Cancer Group

Download Full-text

Faculty Opinions recommendation of Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1108607.564689 ◽

2008 ◽

Author(s):

Michael Leahy

Keyword(s):

Study Protocol ◽

Gynaecological Cancer ◽

Phase Iii ◽

Pelvic Radiotherapy ◽

Uterine Sarcomas ◽

Randomised Study ◽

European Organisation ◽

Cancer Group

Download Full-text

Corrigendum to “Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)” [European Journal of Cancer, 44 (2008) 808–818]

European Journal of Cancer ◽

10.1016/j.ejca.2008.01.029 ◽

2008 ◽

Vol 44 (11) ◽

pp. 1612 ◽

Cited By ~ 4

Author(s):

N.S. Reed ◽

C. Mangioni ◽

H. Malmström ◽

G. Scarfone ◽

A. Poveda ◽

...

Keyword(s):

Study Protocol ◽

Gynaecological Cancer ◽

Phase Iii ◽

Pelvic Radiotherapy ◽

Uterine Sarcomas ◽

Randomised Study ◽

European Organisation ◽

Cancer Group

Download Full-text

Phase II study of carboplatin in patients with advanced or recurrent endometrial carcinoma. A trial of the EORTC Gynaecological Cancer Group

European Journal of Cancer ◽

10.1016/s0959-8049(02)00504-x ◽

2003 ◽

Vol 39 (1) ◽

pp. 78-85 ◽

Cited By ~ 30

Author(s):

F.H van Wijk ◽

C Lhommé ◽

G Bolis ◽

V Scotto di Palumbo ◽

S Tumolo ◽

...

Keyword(s):

Endometrial Carcinoma ◽

Phase Ii ◽

Phase Ii Study ◽

Gynaecological Cancer ◽

Cancer Group

Download Full-text